Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Globenewswire· 2025-05-29 20:01
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted orphan drug designation to BEAM-302, a liver-targeting lipid-nanoparticle (LNP) formulation of a guide RNA and an mRNA encoding a base editor designed to correct the disease-causing mutation in patients with alpha-1 antitrypsin deficiency (AATD ...
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire News Room· 2025-05-29 20:01
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced that it closed its previously announced underwritten public offering of 2,555,555 shares of its common stock, including the full exercise by the underwriters of their option to purchase an additional 333,333 shares, at a public offering price of $9.00 p ...
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
Globenewswire· 2025-05-29 20:01
Company Overview - Kiniksa Pharmaceuticals International, plc is a biopharmaceutical company focused on improving the lives of patients with debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet needs, particularly in cardiovascular indications [2] Upcoming Events - Kiniksa will present at the Jefferies 2025 Global Healthcare Conference on June 5 at 12:50 p.m. Eastern Time [3] - The company will also participate in the Goldman Sachs 46th Annual Global Healthcare Conference on June 10 at 8:00 a.m. Eastern Time, featuring a fireside chat [3] - Live webcasts of Kiniksa's presentations will be available on the company's website, with replays accessible approximately 48 hours after the events [1]
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
Globenewswire· 2025-05-29 20:00
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 9:20 AM Eastern Time at the New York Marriott Marquis Hotel in New York, NY. Interested parties may access the live webcast of the fireside chat by visiting the Investors & Media section of the Cytokinetics website at http ...
NobelClad Celebrates Expansion of Its Dunbar Mine in Collaboration With U.S. Navy and Partner Organizations
Globenewswire· 2025-05-29 20:00
MT. BRADDOCK, Penn., May 29, 2025 (GLOBE NEWSWIRE) -- NobelClad, a business of DMC Global Inc. (Nasdaq: BOOM), welcomed representatives from the U.S. Navy, Navy’s Maritime Industrial Base Program, BlueForge Alliance, and the U.S. Government to celebrate the expansion of its Dunbar Mine — the site of NobelClad’s proprietary explosive welding operations. As a long-standing strategic customer, the U.S. Navy played a key role in funding the project. “The strong partnership we enjoy with the U.S. Navy enabled th ...
ScanTech AI Announces Receipt of Nasdaq Deficiency Letters
Globenewswire· 2025-05-29 20:00
Atlanta, GA, May 29, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a leading innovator in advanced security screening technologies, today announced that the Company received two letters from Nasdaq Listing Qualifications of The Nasdaq Stock Market LLC (“Nasdaq”), related to non-compliance with certain listing requirements. Neither notice has an immediate effect on the listing of the Company’s common stock on The Nasdaq Global Market. On May 22, 2025, the ...
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
Globenewswire· 2025-05-29 20:00
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Goldman Sachs 46th Annual Global Healthcare Conference, taking place June 9-11, 2025. Details for the company’s participation are as follows: Fireside Chat Date: Tuesday, June 10, 2025 Fireside Chat Time: 4:00 pm EDT The webcast f ...
HPQ Announces Non-Broker Private Placement of Units
Globenewswire· 2025-05-29 19:00
NOT FOR DISTRIBUTION TO U.S NEWS WIRES OR DISSEMINATION IN THE U.S MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to announce that it intends to proceed with a non-brokered private placement of 2,300,000 Units to $414,000. The Company intends to use the net proceed to finance its ongoing initiatives and general corporate purpos ...
NevGold Announces Closing of Upsized C$6.0M Brokered Private Placement Financing
Globenewswire· 2025-05-29 18:49
NOT FOR DISTRIBUTION TO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICESVancouver, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has closed its previously-announced brokered private placement financing and concurrent non-brokered financing of units (the “Units”) for gross proceeds of $6,000,000 (the “Offering”). Each Unit, priced at $0.30 per Unit (the “Issue Price”), consists of one c ...
Volvo Trucks Wins Prestigious Design Award for New North American Truck Model
Globenewswire· 2025-05-29 18:31
Core Viewpoint - Volvo Trucks North America's all-new Volvo VNL has won the 2025 Red Dot Award for Product Design in the commercial vehicles category, highlighting its excellence in design and innovation [1][2]. Design and Development - The Volvo VNL underwent six years of intensive research and product development, resulting in a 90% redesign from previous models, tailored for the North American freight transport sector [2][9]. - The design emphasizes fuel efficiency, driver comfort, and safety, featuring a streamlined cab and sloped windshield that reduce aerodynamic drag and improve fuel efficiency by up to 10% compared to legacy models [3][9]. Interior Features - The interior of the Volvo VNL includes a 24-volt electrical architecture with advanced features such as dynamic displays, a Camera Monitor System, and customizable cab configurations, enhancing the driver experience [8][9]. - Positive feedback from drivers indicates that the new design effectively meets their needs, providing a more comfortable and functional driving environment [8][9]. Industry Recognition - The Red Dot Award is a prestigious international design competition, and the recognition of the Volvo VNL signifies a significant achievement in the heavy-duty truck sector [10][11]. - Volvo Trucks has a history of design excellence, having previously won the Red Dot Award in 2021 for the Volvo FM model, reinforcing its commitment to quality and innovation in product design [11][14].